Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01643122 · ClinicalTrials.gov registry record
Validation Study for Endometriosis PRO
A clinical trial, sponsored by Bayer.
- Completed
- Registry status
- 275
- Enrollment target
NCT01643122 is a clinical trial that has completed, run by Bayer. The registered enrollment target is 275 participants.
The verdict
NCT01643122 has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- 275 participants
- Enrollment target
Study Summary
Assess the psychometric properties of the Endometriosis Symptom Diary (ESD) and the Endometriosis Impact Scale (EIS) and provide evidence whether the PRO measures are reliable, valid and able to detect changes over time in approximately 250 patients with mild, moderate or severe endometriosis confirmed by laparoscopy.
Interventions
- OTHER No drug
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 275 participants |
| Start Date | 2012-08 |
| Est. Completion | 2013-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01643122
The ClinicalTrials.gov registry entry for NCT01643122 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 275 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No drug is the first listed.
NCT01643122 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01643122 about?
NCT01643122 is a clinical study titled "Validation Study for Endometriosis PRO". Assess the psychometric properties of the Endometriosis Symptom Diary (ESD) and the Endometriosis Impact Scale (EIS) and provide evidence whether the PRO measures are reliable, valid and able to detect changes over time in approximately 250 patients with mild, moderate or severe endometriosis confir...
What is the current status of trial NCT01643122?
This trial is currently completed. The enrollment target is 275 participants. The study started on 2012-08. Estimated completion is 2013-09.
What interventions are being tested in trial NCT01643122?
The interventions under investigation include: No drug (OTHER).
Who is sponsoring clinical trial NCT01643122?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.